prostate cancer

J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study
Fierce Pharma
Wed, 10/2/24 - 09:50 pm
JNJ
Erleada
prostate cancer
Astellas
Pfizer
Xtandi
Ipsen shelves Cabometyx combo in prostate cancer after Phase III miss
Clinical Trials Arena
Mon, 09/16/24 - 11:07 am
Ipsen
Carbometyx
clinical trials
prostate cancer
ESMO: Bayer hopes to expand Nubeqa's prostate cancer reach with chemo-free regimen
Fierce Pharma
Mon, 09/16/24 - 09:58 am
ESMO
Bayer
Nubeqa
prostate cancer
Blue Earth Therapeutics partners with UCL for prostate cancer therapy trial
Clinical Trials Arena
Wed, 07/24/24 - 11:35 am
Blue Earth Therapeutics
radioligands
prostate cancer
Bayer eyes Nubeqa’s label expansion in prostate cancer following Phase III win
Clinical Trials Arena
Fri, 07/19/24 - 11:55 am
Bayer
clinical trials
Nubeqa
prostate cancer
Trial sets up wider use of Bayer's Nubeqa in prostate cancer
Pharmaphorum
Wed, 07/17/24 - 11:40 am
Bayer
clinical trials
Nubeqa
prostate cancer
mHSPC
Barinthus lays off 25% of staff, sidelines prostate cancer program to stretch out cash
Fierce Biotech
Thu, 06/13/24 - 10:51 am
Barinthus Biotherapeutics
hepatitis B
clinical trials
prostate cancer
layoffs
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial
BioSpace
Fri, 05/24/24 - 11:20 am
ASCO 2024
JNJ
JNJ-6420
prostate cancer
clinical trials
patient deaths
radiopharmaceuticals
Five Deaths in Prostate Cancer Trial Send MacroGenics’ Stock Plummeting
BioSpace
Fri, 05/10/24 - 11:16 am
Macrogenics
clinical trials
antibody-drug conjugate
vobramitamab duocarmazine
prostate cancer
patient deaths
Johnson & Johnson reports data from Phase II prostate cancer trial
Clinical Trials Arena
Mon, 05/6/24 - 11:28 am
JNJ
clinical trials
Erleada
prostate cancer
European Commission approves Astellas’ drug for expanded prostate cancer Treatment
Outsourcing Pharma
Thu, 04/25/24 - 05:59 pm
Astellas
Xtandi
Europe
prostate cancer
Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader
Fierce Biotech
Thu, 04/11/24 - 11:56 am
Novartis
Arvinas
protein degradation
prostate cancer
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data
BioSpace
Fri, 04/5/24 - 11:37 am
Novartis
Pluvicto
prostate cancer
clinical trials
radioligands
Prostate cancer ADC acquired from Fortis breaks FibroGen's clinical losing streak
Fierce Biotech
Thu, 04/4/24 - 10:51 am
FibroGen
antibody-drug conjugate
prostate cancer
FG-3246
Bayer says 2024 sales of prostate cancer drug above $1 bln
Reuters
Thu, 03/21/24 - 10:58 am
Bayer
prostate cancer
Nubeqa
Promontory’s prostate cancer trial reaches patient enrolment milestone
Clinical Trials Arena
Mon, 03/11/24 - 11:41 am
Promontory Therapeutics
clinical trials
PT-112
metastatic castration-resistant prostate cancer
prostate cancer
AI identifies New Type Of Prostate Cancer
Forbes
Thu, 02/29/24 - 06:51 pm
prostate cancer
artificial intelligence
Janux shares triple on early cancer immunotherapy data
BioPharma Dive
Wed, 02/28/24 - 11:08 am
Janux Therapeutics
clinical trials
solid tumors
prostate cancer
T-cell engager
Eli Lilly’s Verzenio fails prostate cancer test as possible Novartis showdown nears
Fierce Pharma
Wed, 02/7/24 - 11:26 am
Eli Lilly
Verzenio
prostate cancer
Pfizer funnels $15M into 3-year ACS initiative designed to tackle cancer care disparities
Fierce Biotech
Mon, 02/5/24 - 10:23 am
Pfizer
American Cancer Society
clinical trials
pharma marketing
breast cancer
prostate cancer

Pages